Holen Sie sich die Stockscreener-App
1.49
2.30%
-0.03
Finanzdaten der Acrivon Therapeutics Inc-Aktie (ACRV)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-09-30 | 2025-07-01 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
19.69
|
- | 21.66 | 24.95 | 25.14 |
| Operating Income/Loss |
-19.69
|
- | -21.66 | -24.95 | -25.14 |
| Nonoperating Income/Loss |
1.453
|
- | 1.982 | 2.123 | 2.699 |
| Income/Loss From Continuing Operations Before Tax |
13.20%
-18.23
|
-21.01 | -19.68 | -22.83 | -22.44 |
| Income/Loss From Continuing Operations After Tax |
13.20%
-18.23
|
-21.01 | -19.68 | -22.83 | -22.44 |
|
Net Income/Loss
|
13.20%
-18.23
|
-21.01 | -19.68 | -22.83 | -22.44 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
38.56
|
- | 38.35 | 1.4944 | 38.11 |
| Diluted Average Shares |
38.56
|
- | 38.35 | 1.4944 | 38.11 |
| Basic Earnings Per Share |
-0.47
|
- | -0.51 | -0.59 | -0.59 |
| Diluted Earnings Per Share |
-0.47
|
- | -0.51 | -0.59 | -0.59 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.99%
3.03%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):